Related Experiment Videos
Colicin M inhibits peptidoglycan biosynthesis by interfering with lipid carrier recycling
1Mikrobiologie II, University of Tübingen, Federal Republic of Germany.
Abstract:
Colicin M is unique among the colicins in that it causes lysis of cells. Synthesis of peptidoglycan was inhibited before colicin-induced cell lysis occurred. This suggested that inhibition of peptidoglycan synthesis was the primary effect of the colicin which was followed by cell lysis. Following colicin M treatment, soluble peptidoglycan nucleotide precursors accumulated, and radioactivity associated with the membrane-bound carrier lipid almost disappeared. Further metabolism of radiolabeled intermediates bound to the lipid carrier (lipid intermediates) was not inhibited by colicin M. The two lipid intermediates decreased to a level where equal amounts of both were present. The data indicated that translocation of nucleotide precursors to the lipid carrier was not inhibited. In vitro peptidoglycan synthesis agreed with the in vivo results. It is concluded that colicin M inhibits peptidoglycan biosynthesis by preventing regeneration of the lipid carrier.
Insights
Colicin M causes cell lysis by inhibiting peptidoglycan synthesis. It prevents the regeneration of the lipid carrier, a key step in bacterial cell wall biosynthesis.
Area of Science:
- Microbiology
- Bacteriology
- Molecular Biology
Background:
- Colicins are bacteriocins produced by bacteria that inhibit or kill related species.
- Colicin M is unique among colicins for inducing cell lysis.
- Peptidoglycan is essential for bacterial cell wall integrity.
Purpose of the Study:
- To elucidate the mechanism by which Colicin M inhibits peptidoglycan synthesis.
- To determine the specific step in peptidoglycan biosynthesis affected by Colicin M.
- To understand the relationship between peptidoglycan synthesis inhibition and cell lysis.
Main Methods:
- In vivo studies of peptidoglycan precursor accumulation and lipid intermediate metabolism in bacteria treated with Colicin M.
- In vitro assays of peptidoglycan synthesis using bacterial extracts.
- Radioactive labeling of peptidoglycan precursors and lipid intermediates.
Main Results:
- Colicin M treatment led to the accumulation of soluble peptidoglycan nucleotide precursors.
- Radioactivity associated with membrane-bound lipid intermediates significantly decreased.
- In vitro synthesis confirmed that Colicin M inhibits peptidoglycan biosynthesis by affecting lipid carrier regeneration.
Conclusions:
- Colicin M inhibits peptidoglycan biosynthesis by preventing the regeneration of the lipid carrier.
- This inhibition of peptidoglycan synthesis is the primary event leading to Colicin M-induced cell lysis.
- The findings provide a detailed understanding of Colicin M's mode of action at the molecular level.